Hocine C - Search Results

1

Prevention of secondary hyperparathyroidism in chronic renal failure before dialysis.

Fournier A, Boudailliez B, Westeel PF, Morinière P, Idrissi A, Belbrik S, Hocine C, Marie A, Cohen Solal ME. Fournier A, et al. Among authors: hocine c. Contrib Nephrol. 1989;71:64-80. doi: 10.1159/000417255. Contrib Nephrol. 1989. PMID: 2680267 Review. No abstract available.

2

Prevention of osteitis fibrosa, aluminium bone disease and soft-tissue calcification in dialysis patients: a long-term comparison of moderate doses of oral calcium +/- Mg(OH)2 vs Al(OH)3 +/- 1 alpha OH vitamin D3.

Morinière P, Boudailliez B, Hocine C, Belbrik S, Renaud H, Westeel PF, Solal MC, Fournier A. Morinière P, et al. Among authors: hocine c. Nephrol Dial Transplant. 1989;4(12):1045-53. Nephrol Dial Transplant. 1989. PMID: 2517325

3

Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experience.

Morinière P, Fournier A, Westeel PF, Idrissi A, Renaud H, Hocine C, Belbrik S, Marie A, Leflon P, Sebert JL. Morinière P, et al. Among authors: hocine c. Contrib Nephrol. 1988;64:58-73. doi: 10.1159/000415728. Contrib Nephrol. 1988. PMID: 3053039 Review. No abstract available.

4

1,25 (OH)2 vitamin D3 deficiency and renal osteodystrophy: should its well-accepted pathogenetic role in secondary hyperparathyroidism lead to its systematic preventive therapeutic use?

Fournier A, Moriniere P, Boudaillez B, Renaud H, Marie A, Westeel PF, Hocine C, Belbrik S. Fournier A, et al. Among authors: hocine c. Nephrol Dial Transplant. 1987;2(6):498-503. Nephrol Dial Transplant. 1987. PMID: 3126450 Review. No abstract available.

5

Long-term efficacy and safety of oral calcium as compared to A1(OH)3 as phosphate binders.

Moriniere P, Hocine C, Boudailliez B, Belbrik S, Renaud H, Westeel PF, Solal MC, Fournier A. Moriniere P, et al. Among authors: hocine c. Kidney Int Suppl. 1989 Nov;27:S133-5. Kidney Int Suppl. 1989. PMID: 2636648 No abstract available.

6

[High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy].

Fournier A, Morinière P, Boudailliez B, Marie A, Westeel PF, Renaud M, Belbrik S, Hocine C, Sebert JL. Fournier A, et al. Among authors: hocine c. Presse Med. 1988 Apr 30;17(16):777-80. Presse Med. 1988. PMID: 2968564 French. No abstract available.

7

Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation.

Morinière P, Vinatier I, Westeel PF, Cohemsolal M, Belbrik S, Abdulmassih Z, Hocine C, Marie A, Leflon P, Roche D, et al. Morinière P, et al. Among authors: hocine c. Nephrol Dial Transplant. 1988;3(5):651-6. doi: 10.1093/oxfordjournals.ndt.a091722. Nephrol Dial Transplant. 1988. PMID: 3146723

8

Evaluation of vascular calcinosis risk factors in patients on chronic hemodialysis: lack of influence of calcium carbonate.

Renaud H, Atik A, Hervé M, Morinière P, Hocine C, Belbrik S, Fournier A. Renaud H, et al. Among authors: hocine c. Nephron. 1988;48(1):28-32. doi: 10.1159/000184864. Nephron. 1988. PMID: 3340252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters